![]() The Asia Working Group for Sarcopenia (AWGS) reported that estimated sarcopenia prevalence in Asia was 4.1% to 11.5%. Sarcopenia prevalence in individuals aged ≥50 years was 1% to 29% in community-dwelling populations, 14% to 33% in long-term care populations, and 10% in the acute hospital-care population, based on criteria defined by the European Working Group on Sarcopenia in Older People (EWGSOP). The global prevalence of sarcopenia in individuals aged ≥60 years is 10% in both men and women, with a higher prevalence in non-Asian populations than Asian populations in both sexes. This primarily geriatric syndrome is characterized by loss of skeletal muscle mass and function, which can be defined based on diminished muscle strength and functional performance. Sarcopenia is a degenerative muscle disease or muscle failure that occurs mainly in older individuals. įunding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.Ĭompeting interests: The authors have declared that no competing interests exist. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.ĭata Availability: All dataset files are available from the. Received: AugAccepted: JanuPublished: February 9, 2021Ĭopyright: © 2021 Ridwan et al. ![]() Alway, University of Tennessee Health Science Center College of Graduate Health Sciences, UNITED STATES (2021) Peak expiratory flow rate and sarcopenia risk in older Indonesian people: A nationwide survey. Future studies should explore the usefulness of PEFR as a risk factor of sarcopenia.Ĭitation: Ridwan ES, Wiratama BS, Lin M-Y, Hou W-H, Liu MF, Chen C-M, et al. Poor lung function was independently associated with sarcopenia occurrence. After adjustment for confounders, PEFRs of 80%. Confounders previously determined to be associated with sarcopenia occurrence were included. Peak expiratory flow rates (PEFRs) were categorized according to their percentage of predicted flow rates as 80%. Sarcopenia was diagnosed based on handgrip strength, gait speed, and appendicular skeletal muscle mass measurements. Community-dwelling Indonesian individuals aged ≥60 years (n = 2422 mean age = 67.21 y) from the fifth-wave data of the Indonesian Family Life Survey was selected. We analyzed nationwide survey data to determine the relationship between peak expiratory flow rate and sarcopenia in older Indonesians. PEF is measured with an instrument known as a peak flow meter: a small device fitted with a mouthpiece and a pointer that slides along a graded scale when air is forced out of the lungs.Reduced peak expiratory flow is a common physiological change in older individuals and age is an important predictor for sarcopenia. Dosage adjustments can be made providing they are in line with the doctor's plan of action (see the ACTION PLAN FOR PERSONS WITH ASTHMA handout published by Vigilance Santé). A drop that exceeds 10 to 15% of one's PEF - along with symptoms indicating a deterioration of respiratory condition (cough, wheezing, shortness of breath) - is sign of an impending attack or the need to adjust dosage. The data collected is used to determine an asthmatic's personal PEF. This is why we recommend measuring PEF daily, morning and night. The data is particularly useful when several readings can be compared on a daily basis, as it allow asthmatics to monitor whether their respiratory condition is deteriorating and if an attack is imminent. In asthmatics however, it will decrease during an asthma attack and when medication is not having the desired effect. In healthy people, PEF does not vary much from day to day. Age, gender, size and the condition of the lungs influence normal PEF values. ![]() It helps determine just how open the airways are. Peak expiratory flow (PEF) is the maximum speed at which a person can forcibly exhale air from the lungs in a single breath. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |